
Fermenters and Aging Equipment Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global fermenters and aging equipment market was estimated at USD 9.2 billion in 2024, and the market is expected to grow from USD 9.7 billion in 2025 to USD 17 billion by 2034, at a CAGR of 6.5%. This is because the applications are growing in industries based on fermentation and aging processes, such as in biopharmaceuticals and food and beverages.

In 2024, the market share of the biopharmaceutical sector was nearly 40%. The increasing need for biopharmaceutical products such as vaccines, monoclonal antibodies, and biologics has increased the demand for advanced fermentation technologies. According to the World Health Organization (WHO), demand for vaccines in the world has seen over 30% growth over the last ten years, increasing further demand for fermenters. Additionally, chronic diseases and increasing healthcare expenditure globally have fueled investment in improved fermentation systems. Advanced technologies such as single-use fermenters and automation have introduced greater efficiency through lower contamination opportunities and downtime, thus prompting biopharma firms to invest in newer machinery.
The food and beverages sector contributed about 30% to the business. This is a result of rising customer demand for fermented foods and beverages such as beer, wine, alcohol, and dairy products. The Food and Agriculture Organization (FAO) observes that global consumption of dairy grew at an average rate of 1.8% annually between 2015 and 2022, and this has been accompanied by rising demand for fermentation equipment. Higher consumption of craft and premium drinks has also stimulated demand for aging equipment to flavor the products and give them quality credentials. Also, increasing focus on natural and sustainable food processing has resulted in increased application of fermenters and aging technology.
The largest market share in 2024 is APAC, at 38.1%. This is because there has been intense industrialization, increased investment in biopharmaceutical manufacturing, and increased production of food and beverages in China, India, Japan, and South Korea. Health spending in APAC rose 7.5% annually from 2010 to 2022, as per the Asian Development Bank (ADB), thereby promoting demand for vaccines and biologics that are produced through fermentation. Increased disposable income and lifestyle modifications have also powered alcoholic beverages' growth more rapidly, further establishing regional supremacy.
Across the world, the market for fermenters and aging equipment is dominated by major companies that possess robust technology, extensive product lines, and profound sales networks. Sartorius AG, Eppendorf AG, Parker Hannifin Corporation, Thermo Fisher Scientific, GE Healthcare (Cytiva), Applikon Biotechnology, and SPX Flow are the leading companies dominating the industry. Through research and development, the companies enhance the performance of the equipment and satisfy different customer requirements, thereby securing their positions in the industry.
Overall, the market for fermenters and aging equipment is likely to grow with moderate growth through the growth in the biopharmaceutical and food and beverages industries, technological advancements, and industrialization in emerging economies such as APAC. The new entrants of innovative products by prominent global companies also favor the prospects of the market through 2030.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 9.2 Billion |
| Forecast Period 2025 - 2034 CAGR | 6.5% |
| Market Size in 2034 | USD 17 Billion |
| Key Market Trends | |
| Drivers | Impact |
| Rising Demand for Biopharmaceuticals | The growing production of vaccines, monoclonal antibodies, and other biologics necessitates cutting-edge fermentation technology, driving industry growth. |
| Growth of the Food & Beverage Industry | Increased consumer demand for fermented foods like beer, wine, dairy, and other specialty foods contributes to growing demand for sophisticated fermenters and aging equipment to ensure quality and taste. |
| Technological Advancements | Fermenters such as single-use fermenters, automation, and process optimization enhance operational efficiency, reduce the cost of contamination, and reduce expenditure, thus resulting in adoption across diverse industries. |
| Pitfalls & Challenges | Impact |
| High Capital Investment | Capital outlay on sophisticated fermenters and aging machines is likely to be substantial at the start, and this acts as a deterrent to adoption, especially for new firms and small-scale producers. |
| Complexity of Operation and Maintenance | Advanced equipment demands technical staff to work on and operate it, and that is not always possible in low-technology settings. |
| Opportunities: | Impact |
| Growing Demand for Sustainable and Natural Fibers | Rising consumer preference for eco-friendly and biodegradable textiles is boosting wool demand, encouraging investment in modern processing machinery. |
| Automation and Industry 4.0 Adoption | The integration of automation, AI, and IoT in wool processing equipment improves efficiency, reduces labor dependency, and ensures consistent product quality. |
| Market Leaders (2024) | |
| Market Leaders |
3.2% market share |
| Top Players |
Collective Market Share in 2024 is 9% |
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | Asia Pacific |
| Fastest Growing Market | Asia Pacific |
| Emerging Country | China, India, South Korea |
| Future outlook |
|
The fermenter and aging plant equipment market is evolving with the dominance of top trends that are driving innovation and impacting purchasing decisions in industries. These trends are informed by emerging technology, increasing regulation, and sustainability, which are altering manufacturers' strategies for developing and using fermenters and aging systems.


Based on the operation, the fermenters and aging equipment market is segmented into batch fermentation, fed-batch fermentation, and continuous fermentation. In 2024, the batch fermentation segment accounted for over 53.4% and is expected to grow at a rate of 7.3% till 2034.
Based on the distribution channel, the market is segmented into direct and indirect. The direct segment is expected to hold a major share of 65.9% in 2024.

In 2024, the U.S dominated the fermenters and aging equipment market, accounting for around 67.7% of the North American market share and generating around USD 1.7 billion in revenue in the same year.
The European fermenters and aging equipment market in Germany is expected to experience significant and promising growth from 2025 to 2034.
The APAC fermenters and aging equipment market in China is expected to experience significant and promising growth with a 7.5% CAGR from 2025 to 2034.
The MEA Fermenters and Aging Equipment market in the UAE is expected to experience significant and promising growth from 2025 to 2034.
Sartorius AG, Thermo Fisher Scientific, Merck KGaA (MilliporeSigma), GEA Group AG, and Alfa Laval AB lead with 9% market share. The top 3 companies collectively hold 6% market share, indicating low market concentration.
Over the last 2–3 years, these two companies have grown market share with the growing demand for premium bioprocessing equipment. This is rising with greater biopharmaceutical production and more fermented food products and beverage companies. Both Sartorius and Thermo Fisher have made significant progress on the back of a strategy of emphasizing single-use and automated fermenters, which are in high demand.
Both are well-placed in their way to thrive. Sartorius is a single-use bioreactor and end-to-end bioprocess solutions provider that offers biopharma customers across the globe. Thermo Fisher has product and service-integrated solutions based on life sciences expertise to provide end-to-end process solutions. Merck KGaA (MilliporeSigma) has a focus on reagents and tools for life science, providing high-quality fermentation platforms. GEA Group has specialty large-scale fermentation equipment for food and beverages with advanced automation to complement it. Alfa Laval is the heat transfer, separation, and fluid handling systems leader dedicated to maximizing the efficiency and sustainability of fermentation.
They are growing by growth via acquisitions, product development, and geographically in growth economies. Sartorius bought BIA Separations and Xell AG to enhance its bioprocessing scale. Thermo Fisher bought PPD and invested in bioproduction. Merck set up its M Lab™ Collaboration Centers and developed next-generation fermentation and filtration technology. GEA builds energy-efficient fermentation modules to take advantage of trendy food, and Alfa Laval focuses on equipment digitalization and sustainability.
These companies do have problems, though. Asian start-ups and manufacturers are bringing in lower-cost or specialty products, particularly in flexible and modular equipment. Emerging technologies such as process control using artificial intelligence and continuous fermentation can turn things around if they pan out. Supply chain interruptions and regulatory shifts, particularly environmental requirements and biologic manufacturing, also require continual flexibility. Despite all the aforementioned problems, the dominant strategies, technology, and size of these five companies are overwhelming the fermenter market and aging equipment.
Major players operating in the fermenters and aging equipment industry are:
The leading 15 fermenter and aging equipment manufacturers have a wide range of capabilities, strategic focus, and technological innovation shaping the competitive environment. Alfa Laval uses its capabilities in fluid handling as well as heat exchange technology to provide environmentally friendly and energy-efficient solutions to fermenters, mainly for food and beverage applications. Getinge-held Applikon Biotechnology is a high-performance bioreactor system R&D pioneer that has strengthened its position through tailored small-scale fermentation platforms.
Bioengineering AG is a Switzerland-based company that specializes in made-to-measure fermenter and bioreactor systems for high-end biopharma and R&D laboratories. The company specializes in modular and GMP technologies, making it a preferred point of reference for scale-up solutions. Bucher Vaslin targets mostly the wine sector with its emerging aging technology and fermentation systems, investing in tender processing and precision control systems to ensure flavor integrity. Danaher Corporation, led by subsidiaries such as Cytiva (former GE Life Sciences), has strategically placed itself in the bioprocessing continuum through turnkey fermentation solutions. It continues to expand through acquisition and alliance, its latest acquisition being Precision NanoSystems.
Eppendorf provides well-automated, bench-top fermenters and bioreactors for laboratory applications and targets software integration for data management and remote monitoring. Its user-friendly system design makes it a solid contender in the biotech startup and academic markets. GEA Group is particularly strong in large-capacity fermentation and aging systems, particularly in dairy and beverage markets, and is continuing to advance on energy efficiency and digitalized plant control. Merck KGaA, through MilliporeSigma, has significantly invested in R&D and global growth, including the opening of M Lab™ Collaboration Centers and enhancing its line of scalable, disposable fermenters.
Paul Mueller Company has built a niche around stainless steel tanks and fermenters, particularly in dairy, brewery, and pharma markets. Its local U.S.-based manufacturing and commitment to custom engineering provide it with a unique regional impact. Sartorius has come a long way with acquisitions such as BIA Separations and is committed to single-use technologies and upstream bioprocess automation. STS Canada provides custom fermenter design for industrial biotechnology and is committed to enormous flexibility and optimization of performance.
Tetra Pak, more familiar with food processing, has entered fermentation with end-to-end automation solutions for dairy and plant-based food, with emphasis on its end-to-end approach. Thermo Fisher Scientific offers end-to-end fermentation and aging capabilities as part of its overall life sciences offering, launching new products every month for equipment for bioproduction. Ziemann Holvrieka offers large-volume brewing and aging tanks, still maintaining its global beverage customers with engineering-intensive fermentation systems. Finally, JVNW specializes in North American craft breweries and food processors' custom stainless steel fermenters and emphasizes design freedom and customized customer service as its attributes.
Market, By Equipment Type
Market, By Operation
Market, By Automation Level
Market, By Material of Construction
Market, By Application
Market, By Distribution Channel
The above information is provided for the following regions:
Key players operating in the market include Alfa Laval, Applikon Biotechnology, Bioengineering AG, Bucher Vaslin, Danaher Corporation, Eppendorf AG, GEA Group, and Merck KGaA.
Key trends include adoption of single-use technologies, which enhance fermentation processes by reducing contamination risks and eliminating cleaning and sterilization requirements between operations.
The U.S. dominated the market, accounting for 67.7% of the North American market share and generating around USD 1.7 billion in revenue in 2024.
The global market was estimated at USD 9.2 billion in 2024, with a CAGR of 6.5% expected through 2034, driven by expanding applications in biopharmaceuticals and food and beverages industries.
The batch fermentation segment accounted for 53.4% market share and is expected to grow at a rate of 7.3% till 2034.
The fermenters segment generated USD 6.1 billion in 2024 and is expected to grow at a CAGR of 6.9% during the forecast period.
The market is expected to grow from USD 9.7 billion to USD 17 billion by 2034, driven by technological advancements, regulatory requirements, and sustainability considerations.


